Pain Medicine, Interventional Pain Medicine · Englewood, FL
NPI
1619919529
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2103 S McCall Rd
Englewood, FL, 34224
Phone (941) 441-9007
Groups this clinician bills Medicare through
Medicare paid, 2024
$439K
11,186 services
Medicare patients, 2024
332
Average age 73
Drug cost, 2024
$317K
5,549 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lew A Little was code J3301 (injection, triamcinolone acetonide, not otherwise specified, 10 mg), 4,118 times for 205 patients. In total Lew A Little billed 11,186 services in 40 codes, and Medicare paid $439K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 4,118 | 205 | $0.77 | $3,169 |
| 97140 PT Treatment | Office | 3,257 | 104 | $16.47 | $54K |
| 99214 Office E&M - Established | Office | 1,758 | 269 | $91.00 | $160K |
| 99215 Office E&M - Established | Office | 407 | 224 | $132.43 | $54K |
| 80305 Drug Tests | Office | 359 | 207 | $12.35 | $4,434 |
| 99213 Office E&M - Established | Office | 217 | 107 | $64.57 | $14K |
| J1240 Injection, dimenhydrinate, up to 50 mg | Office | 136 | 99 | $6.93 | $942 |
| 64494 Nerve Block Injection - Back | Office | 125 | 91 | $94.84 | $12K |
| 64493 Nerve Block Injection - Back | Office | 125 | 91 | $180.93 | $23K |
| 64635 Destruction by Neurolytic Agent - Back | Office | 88 | 73 | $460.14 | $40K |
| G3002 Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 87 | 70 | $64.44 | $5,606 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 84 | 70 | $252.21 | $21K |
| 99205 Office E&M - New | Office | 57 | 57 | $160.75 | $9,163 |
| 99442 Telephone Services | Office | 40 | 34 | $64.80 | $2,592 |
| 20610 Joint Injection | Office | 37 | 24 | $49.54 | $1,833 |
By year: 2022 $595K for 12,498 services; 2023 $526K for 11,043 services; 2024 $439K for 11,186 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 359 | 207 | $12.35 | $4,434 |
Medicare prescription drug claims, 2024
In 2024, the drug Lew A Little prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,077 prescriptions and refills. In total Lew A Little wrote 5,549 Medicare prescriptions that cost $317K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,077 | 1,079 | 140 | $28K |
| Oxycodone Hcl Generic | 753 | 753 | 83 | $13K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 438 | 438 | 58 | $13K |
| Gabapentin Generic | 366 | 437 | 47 | $4,172 |
| Buprenorphine Hcl Generic | 333 | 333 | 34 | $9,339 |
| Cyclobenzaprine Hcl Generic | 302 | 335 | 54 | $2,646 |
| Morphine Sulfate Er Morphine Sulfate | 251 | 251 | 30 | $5,840 |
| Diazepam Generic | 197 | 197 | 88 | $516 |
| Tramadol Hcl Generic | 193 | 193 | 40 | $1,298 |
| Methocarbamol Generic | 143 | 149 | 21 | $1,103 |
| Tizanidine Hcl Generic | 141 | 151 | 20 | $846 |
| Pregabalin Generic | 126 | 172 | 19 | $1,907 |
| Buprenorphine Generic | 121 | 121 | 23 | $20K |
| Meloxicam Generic | 95 | 127 | 17 | $335 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 84 | 85 | 11 | $19K |
Brand drugs: 383 claims; generic drugs: 5,166 claims; opioid claims: 3,324.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Lew A Little were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.